JP2023510865A5 - - Google Patents
Info
- Publication number
- JP2023510865A5 JP2023510865A5 JP2022542777A JP2022542777A JP2023510865A5 JP 2023510865 A5 JP2023510865 A5 JP 2023510865A5 JP 2022542777 A JP2022542777 A JP 2022542777A JP 2022542777 A JP2022542777 A JP 2022542777A JP 2023510865 A5 JP2023510865 A5 JP 2023510865A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- approximately
- angiolipoma
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062966577P | 2020-01-28 | 2020-01-28 | |
| US62/966,577 | 2020-01-28 | ||
| PCT/IB2021/000035 WO2021152390A1 (en) | 2020-01-28 | 2021-01-27 | Compositions for the treatment of angiolipoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510865A JP2023510865A (ja) | 2023-03-15 |
| JP2023510865A5 true JP2023510865A5 (https=) | 2023-12-13 |
| JP7850665B2 JP7850665B2 (ja) | 2026-04-23 |
Family
ID=77078612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542777A Active JP7850665B2 (ja) | 2020-01-28 | 2021-01-27 | 血管脂肪腫の処置のための組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230089484A1 (https=) |
| EP (1) | EP4096653A4 (https=) |
| JP (1) | JP7850665B2 (https=) |
| CN (1) | CN115335047B (https=) |
| AU (1) | AU2021213469A1 (https=) |
| IL (1) | IL295014A (https=) |
| WO (1) | WO2021152390A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3307323B1 (en) | 2015-06-15 | 2022-07-13 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
| AU2020347539A1 (en) * | 2019-09-15 | 2022-03-31 | Raziel Therapeutics Ltd. | Compositions for the treatment of solid tumors |
| JP2024529906A (ja) * | 2021-07-28 | 2024-08-14 | ラジエル セラピューティクス エルティーディー． | 脂肪腫の疼痛を処置するための組成物および方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102712601A (zh) * | 2009-11-12 | 2012-10-03 | 赛尔维他股份公司 | 化合物、其制备方法、药物组合物、化合物的用途、用于调节或调控丝氨酸/苏氨酸激酶的方法以及丝氨酸/苏氨酸激酶调节剂 |
| KR101986272B1 (ko) * | 2011-11-15 | 2019-06-05 | 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | 삼환식 화합물, 이를 포함하는 조성물 및 그의 용도 |
| RU2020111934A (ru) * | 2013-10-08 | 2020-04-29 | Промедиор, Инк. | Способы лечения фиброзного рака |
| EP3060215A4 (en) * | 2013-10-21 | 2017-06-14 | Alevere Medical Corporation | Fused heterocyclic organic compounds, pharmaceutical compositions, and medical uses thereof |
| WO2016020919A1 (en) * | 2014-08-07 | 2016-02-11 | Raziel Therapeutics Ltd. | Compositions comprising tricyclic compounds, and uses thereof |
| EP3307323B1 (en) | 2015-06-15 | 2022-07-13 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
-
2021
- 2021-01-27 US US17/795,204 patent/US20230089484A1/en active Pending
- 2021-01-27 EP EP21748312.2A patent/EP4096653A4/en active Pending
- 2021-01-27 WO PCT/IB2021/000035 patent/WO2021152390A1/en not_active Ceased
- 2021-01-27 IL IL295014A patent/IL295014A/en unknown
- 2021-01-27 CN CN202180025551.1A patent/CN115335047B/zh active Active
- 2021-01-27 JP JP2022542777A patent/JP7850665B2/ja active Active
- 2021-01-27 AU AU2021213469A patent/AU2021213469A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510865A5 (https=) | ||
| JP2024543983A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2022533069A5 (https=) | ||
| JP2020533352A5 (https=) | ||
| JP2022515197A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2021501754A5 (https=) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2023535815A5 (https=) | ||
| JP2021530513A5 (https=) | ||
| JP2006507326A5 (https=) | ||
| JP2021102643A5 (https=) | ||
| CA2361364A1 (en) | Dalda analogs and their use | |
| JP2024545787A5 (https=) | ||
| JP2019520344A5 (https=) | ||
| JP2022509206A5 (https=) | ||
| JP2019529460A5 (https=) | ||
| JP2022533939A5 (https=) | ||
| JP2023538524A5 (https=) | ||
| JP2023505434A5 (https=) | ||
| JP2023503769A5 (https=) | ||
| JP2024507414A5 (https=) | ||
| JP2024538730A5 (https=) | ||
| JP2024517769A5 (https=) |